Latest IR information
IR News
- 2024.07.12
- SymBio Pharmaceuticals Announces Publication of Research Showing Antiviral Drug Brincidofovir Inhibits Infectious Viral Production of Polyomavirus
- 2024.06.24
- Confirmed Antitumor Effects of Brincidofovir in Peripheral T-Cell Lymphoma Suppression of the oncogenic MYC and Induction of Expression of Immunogenic Response Pathways
- 2024.06.11
- SymBio Announces Enrollment of the First Patient of Phase 2a Clinical Trial of Intravenous Brincidofovir for Treatment of Cytomegalovirus Infection after Hematopoietic Stem Cell Transplantation
- 2024.06.03
- Notice of Appointment of Corporate Officer
- 2024.05.13
- 株主通信「SymBio VISION vol.25」(Japanese only)
- 2024.05.08
- SymBio Announces Initiation of Phase 2a Clinical Trial (ATHENA) of Intravenous Brincidofovir for Treatment of Cytomegalovirus Infection after Hematopoietic Stem Cell Transplantation